Florey Biosciences, Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Apr 2025 | $1 M | No. 1 | Under $2 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Florey Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2025).
SEC Form D · Apr 2025
The industry group it chose in its notices: Biotechnology.
SEC Form D · Apr 2025
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Florey Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Andres Fernando Cubillos Ruiz | Executive officer | Apr 2025 |
| Raphael Fernando Gayet | Executive officer | Apr 2025 |
| Andres Fernando Cubillos Ruiz | Director | Apr 2025 |
| Mark Fernando Smith | Director | Apr 2025 |
| Peter Fernando Hutt | Director | Apr 2025 |